BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18185152)

  • 1. Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model.
    Bakri SJ; Pulido JS; Mukherjee P; Marler RJ; Mukhopadhyay D
    Retina; 2008 Jan; 28(1):147-9. PubMed ID: 18185152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model.
    Bakri SJ; Cameron JD; McCannel CA; Pulido JS; Marler RJ
    Am J Ophthalmol; 2006 Jul; 142(1):162-4. PubMed ID: 16815270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal toxicity of indocyanine green in albino rabbits.
    Goldstein M; Zemel E; Loewenstein A; Perlman I
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2100-7. PubMed ID: 16639021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of the photosensitizer NPe6 following intravitreal injection.
    El-Dessouky ES; Moshfeghi AA; Peyman GA; Yoneya S; Mori K; Kazi AA; Moshfeghi DM
    Ophthalmic Surg Lasers; 2001; 32(4):316-21. PubMed ID: 11475398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes.
    Albini TA; Abd-El-Barr MM; Carvounis PE; Iyer MN; Lakhanpal RR; Pennesi ME; Chevez-Barrios P; Wu SM; Holz ER
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):390-5. PubMed ID: 17197559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravitreal morphine administered at different time points after reperfusion in a rabbit model of ischemic retinopathy.
    Riazi-Esfahani M; Kiumehr S; Asadi-Amoli F; Dehpour AR
    Retina; 2009 Feb; 29(2):262-8. PubMed ID: 18854781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.
    Komarowska I; Heilweil G; Rosenfeld PJ; Perlman I; Loewenstein A
    Retina; 2009 Jan; 29(1):98-105. PubMed ID: 18626418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular toxicity of intravitreal tacrolimus.
    Passos E; Genaidy MM; Peyman GA
    Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal toxicity of intravitreal kenalog in albino rabbits.
    Lang Y; Zemel E; Miller B; Perlman I
    Retina; 2007; 27(6):778-88. PubMed ID: 17621190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine pretreatment provides histologic protection against ischemia-reperfusion injury in rabbit retina.
    Riazi-Esfahani M; Kiumehr S; Asadi-Amoli F; Lashay AR; Dehpour AR
    Retina; 2008 Mar; 28(3):511-7. PubMed ID: 18327147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study.
    Schuettauf F; Haritoglou C; May CA; Rejdak R; Mankowska A; Freyer W; Eibl K; Zrenner E; Kampik A; Thaler S
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3573-8. PubMed ID: 16877431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of intravitreal hyaluronidase. A clinical and histologic study.
    Gottlieb JL; Antoszyk AN; Hatchell DL; Saloupis P
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2345-52. PubMed ID: 2242999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.
    Gao H; Pennesi M; Shah K; Qiao X; Hariprasad SM; Mieler WF; Wu SM; Holz ER
    Trans Am Ophthalmol Soc; 2003; 101():183-9; discussion 189. PubMed ID: 14971576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baculovirus is an efficient vector for the transduction of the eye: comparison of baculovirus- and adenovirus-mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye.
    Kinnunen K; Kalesnykas G; Mähönen AJ; Laidinen S; Holma L; Heikura T; Airenne K; Uusitalo H; Ylä-Herttuala S
    J Gene Med; 2009 May; 11(5):382-9. PubMed ID: 19263462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control.
    Pulido JS; Bakri SJ; Valyi-Nagy T; Shukla D
    Retina; 2007 Oct; 27(8):1071-3. PubMed ID: 18040247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.
    Gao H; Pennesi ME; Qiao X; Iyer MN; Wu SM; Holz ER; Mieler WF
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1606-11. PubMed ID: 16565399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of intravitreal ketorolac and diclofenac: an electroretinographic and histopathologic study.
    Kim SJ; Adams NA; Toma HS; Belair ML; Thorne JE; Green WR; Jabs DA
    Retina; 2008 Apr; 28(4):595-605. PubMed ID: 18398362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular use of rituximab.
    Kitzmann AS; Pulido JS; Mohney BG; Baratz KH; Grube T; Marler RJ; Donaldson MJ; O'Neill BP; Johnston PB; Johnson KM; Dixon LE; Salomao DR; Cameron JD
    Eye (Lond); 2007 Dec; 21(12):1524-7. PubMed ID: 17464308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.